Mental Health

This time of year tends to be a roller coaster of ups and downs, but 2020, unsurprisingly, poses unique challenges

The rise in depression and anxiety is even worse than expected, especially among young adults

Oregon became the first state to legalize therapeutic use of the drug as new research affirms its benefits for treating depression

Stanford neurobiologist Andrew Huberman discusses the two things we can always control, even during a high-stress election and scary COVID pandemic

Depression and anxiety have risen amid the pandemic; immersive therapeutics can help

Brain-scan studies hint that the ancient practice may benefit areas associated with memory, emotion and thinking

A pushback has arisen to seasonal clock changes that affect mood, sleep and general well-being

Scientific American’s senior medicine editor Josh Fischman talks about issues in medicine and public health that will be affected by this election.

Journalist Robert Whitaker is more concerned than ever that psychiatric medications do more harm than good

A new mental health treatment using the psychedelic compound psilocybin raises questions about medicine and values

Anxiety about social distancing and infection is altering how much we dream and the nature of our dreams themselves

Studies suggest that we are finding ways to connect even amid quarantine